Class action lawsuits against genetic testing companies over PGT-A
By Ruth Retassie,
PET
| 10. 21. 2024
Former IVF patients in the USA have filed class action lawsuits against several companies for misleading them about the efficacy of PGT-A.
Class action lawsuits have been filed against CooperGenomics, CooperSurgical, The Cooper Companies, Reproductive Genetic Innovations, Progenesis, and Natera by former patients to recuperate funds spent on preimplantation genetic testing for aneuploidy (PGT-A). The lawsuits allege that these companies engaged in consumer fraud and breach of warranty by selling PGT-A to IVF patients, without disclaiming that this test is unproven, experimental, and entails risks of both misdiagnosis and embryo damage during the biopsy. The plaintiffs and class action members claim they would not have purchased testing if given accurate information about its efficacy.
Paula Bliss, partner and co-founder of Justice Law Collaborative and counsel for the plaintiffs, said: 'Our clients have been forced to make consequential decisions based on PGT-A testing that was falsely marketed as having unproven benefits... we seek justice on their behalf.'
PGT-A is conducted to analyse the chromosomal makeup of embryos. The aim is to improve chances of a live birth...
Related Articles
GeneWatch UK has prepared a briefing on the genetic modification of nature for the International Union for Conservation of Nature (IUCN) Congress in October 2025
The upcoming Congress claims to be “where the world comes together to set priorities and drive conservation and sustainable development action.” A major concern for those on the outside is that the Congress may advance plans to develop and encourage the use of synthetic biology in nature conservation. This could at first glance sound like...
By Aaron Ginn, The Washington Post | 09.12.2025
Earlier this year, I had dinner in D.C. with Jensen Huang, the president and chief executive of Nvidia. At one point, he said something that struck me: “Why is everyone here so negative?”
He wasn’t referring to the economy...
By Roni Caryn Rabin, The New York Times | 08.25.2025
Scientists have dreamed for centuries about using animal organs to treat ailing humans. In recent years, those efforts have begun to bear fruit: Researchers have begun transplanting the hearts and kidneys of genetically modified pigs into patients, with varying degrees...
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...
